Therapeutic concentrations of indinavir in cerebrospinal fluid of HIV-1-infected patients

被引：0
|
作者：
Brinkman, K [1 ]
Kroon, F
Hugen, PWH
Burger, DM
机构：
[1] Univ Nijmegen Hosp, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Acad Hosp Leiden, Dept Infect Dis, Leiden, Netherlands
[3] Univ Nijmegen Hosp, Dept Clin Pharm, NL-6500 HB Nijmegen, Netherlands
来源：
AIDS | 1998年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：537 / 537
页数：1
相关论文
共 50 条
  • [1] Indinavir in cerebrospinal fluid of HIV-1-infected patients
    Ståhle, L
    Martin, C
    Svensson, JO
    Sönnerborg, A
    LANCET, 1997, 350 (9094): : 1823 - 1823
  • [2] Darunavir Concentrations in Cerebrospinal Fluid and Blood in HIV-1-Infected Individuals
    Yilmaz, Aylin
    Izadkhashti, Arash
    Price, Richard W.
    Mallon, Patrick W.
    De Meulder, Marc
    Timmerman, Philip
    Gisslen, Magnus
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (04) : 457 - 461
  • [3] Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients
    Zhou, XJ
    Havlir, DV
    Richman, DD
    Acosta, EP
    Hirsch, M
    Collier, AC
    Tebas, P
    Sommadossi, JP
    AIDS, 2000, 14 (18) : 2869 - 2876
  • [4] Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy
    Gisolf, EH
    van Praag, RME
    Jurriaans, S
    Portegies, P
    Goudsmit, J
    Danner, SA
    Lange, JMA
    Prins, JM
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (05) : 426 - 433
  • [5] Pharmacokinetics of hydroxyurea in plasma and cerebrospinal fluid of HIV-1-infected patients
    Gwilt, PR
    Manouilov, KK
    McNabb, J
    Swindells, SS
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (09): : 1003 - 1007
  • [6] Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination
    Duval, Xavier
    Peytavin, Gilles
    Breton, Guillaume
    Ecobichon, Jean-Luc
    Descamps, Diane
    Thabut, Gabriel
    Leport, Catherine
    AIDS, 2007, 21 (01) : 106 - 108
  • [7] Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-1-infected patients
    Rolinski, B
    Bogner, JR
    Sadri, I
    Wintergerst, U
    Goebel, FD
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 15 (03): : 192 - 197
  • [8] Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment
    Rozek, Wojciech
    Ricardo-Dukelow, Mary
    Holloway, Sondra
    Gendelman, Howard E.
    Wojna, Valerie
    Melendez, Loyda. M.
    Ciborowski, Pawel
    JOURNAL OF PROTEOME RESEARCH, 2007, 6 (11) : 4189 - 4199
  • [9] Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity
    Wasmuth, J.-C.
    Lambertz, I.
    Voigt, E.
    Vogel, M.
    Hoffmann, C.
    Burger, D.
    Rockstroh, J. K.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (10) : 901 - 908
  • [10] Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity
    J.-C. Wasmuth
    I. Lambertz
    E. Voigt
    M. Vogel
    C. Hoffmann
    D. Burger
    J. K. Rockstroh
    European Journal of Clinical Pharmacology, 2007, 63 : 901 - 908
12345